Nakornthon Hospital PCL (BKK:NKT)
Thailand · Delayed Price · Currency is THB 4.280
-0.020 (-0.47%)
At close: Aug 1, 2025, 4:30 PM ICT
Theseus Pharmaceuticals Cash Flow Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 227.64 | 233.7 | 282.29 | 320.91 | 183.24 | 88.22 |
Depreciation & Amortization | 123.98 | 124.85 | 128.29 | 106.95 | 101.96 | 95.36 |
Other Amortization | 6.72 | 6.72 | 4.97 | - | - | - |
Loss (Gain) From Sale of Assets | 0.76 | 0.83 | -1.09 | -0.18 | -0.4 | -2.78 |
Loss (Gain) From Sale of Investments | 1.79 | 0.71 | -2.35 | -1.45 | -1.13 | -3 |
Provision & Write-off of Bad Debts | 3.35 | 1.85 | 4.44 | -0.57 | 5.33 | 4.78 |
Other Operating Activities | -8.68 | -7.81 | -2.02 | 18.29 | 16.52 | -9.06 |
Change in Accounts Receivable | -10.4 | -3.56 | 0.27 | -25.78 | -19.2 | -2.26 |
Change in Inventory | -5.86 | -1.03 | -0.26 | -2.32 | -4.1 | 0.54 |
Change in Accounts Payable | 3.09 | 1.31 | -26.85 | 49.2 | 4.49 | -10.09 |
Change in Unearned Revenue | 0.2 | 3.72 | 3.6 | -0.18 | 1.97 | -3.03 |
Change in Other Net Operating Assets | 9.56 | -8.44 | -9.83 | -10.58 | 20.26 | -0.5 |
Operating Cash Flow | 352.17 | 352.86 | 381.46 | 454.29 | 308.94 | 158.18 |
Operating Cash Flow Growth | -7.68% | -7.50% | -16.03% | 47.05% | 95.30% | - |
Capital Expenditures | -376.2 | -247.51 | -169.58 | -187 | - | - |
Sale of Property, Plant & Equipment | 0.77 | 0.62 | 1.2 | 0.57 | 0.66 | 3.52 |
Sale (Purchase) of Intangibles | -1.37 | -1.35 | -5.27 | -8.93 | -0.23 | -1.58 |
Sale (Purchase) of Real Estate | - | - | - | -54.4 | -9.18 | -17.96 |
Investment in Securities | 384.34 | 494.4 | 0.21 | -210 | -109.99 | 85.43 |
Other Investing Activities | 0.21 | 0.21 | -0.46 | -0.21 | -168.46 | -85.19 |
Investing Cash Flow | 7.74 | 246.37 | -173.9 | -459.97 | -287.19 | -15.78 |
Short-Term Debt Issued | - | 50 | - | - | - | - |
Long-Term Debt Issued | - | 300 | - | - | - | - |
Total Debt Issued | 350 | 350 | - | - | - | - |
Long-Term Debt Repaid | - | -200 | - | -0.31 | -0.46 | -3.34 |
Net Debt Issued (Repaid) | - | 150 | - | -0.31 | -0.46 | -3.34 |
Issuance of Common Stock | 1,053 | 1,053 | - | - | - | - |
Common Dividends Paid | -873.96 | -873.96 | -99.97 | -43.77 | -19.92 | -32.36 |
Other Financing Activities | -31.69 | -31.69 | - | 0 | - | - |
Financing Cash Flow | 147.35 | 297.35 | -99.97 | -44.08 | -20.38 | -35.7 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | 139.1 | 34.64 |
Net Cash Flow | 507.26 | 896.58 | 107.59 | -49.76 | 140.47 | 141.34 |
Free Cash Flow | -24.03 | 105.34 | 211.88 | 267.3 | 308.94 | 158.18 |
Free Cash Flow Growth | - | -50.28% | -20.73% | -13.48% | 95.30% | - |
Free Cash Flow Margin | -1.19% | 5.21% | 10.40% | 13.65% | 20.04% | 11.49% |
Free Cash Flow Per Share | -0.06 | 0.26 | 0.53 | 0.67 | 0.77 | 0.40 |
Cash Interest Paid | 6.76 | 6.51 | - | 0.01 | 0.03 | 0.37 |
Cash Income Tax Paid | 69.03 | 69.26 | 79.39 | 57.44 | 27.25 | 23.89 |
Levered Free Cash Flow | -460.99 | 122.48 | 131.42 | 346.52 | 211.07 | - |
Unlevered Free Cash Flow | -453.57 | 129.79 | 134.43 | 346.53 | 211.09 | - |
Change in Net Working Capital | 388.22 | -61.5 | 47.65 | -186.58 | 29.92 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.